Innate Pharma SA (IPHA) said Monday it has appointed Jonathan Dickinson as chief executive officer and chairman of the executive board, effective Nov. 1, replacing Herve Brailly.

Dickinson most recently served as executive vice president and general manager for Europe at Incyte (INCY).

Brailly, who served as interim CEO, will stay in an advisory role during the transition process, the company said.